Wird geladen...
Outcomes for patients managed by Redo Craniotomy or Bevacizumab for pseudo-progression or true progression occurring within six months of adjuvant RT for glioblastoma
PURPOSE: Minimal evidence exists to support decision-making that occurs at the time of symptomatic steroid refractory pseudo-progression or true progression occurring within six months of IMRT for GBM. This study aimed to audit the survival outcome of patients with managed with either redo craniotom...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168818/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy130.080 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|